Abstract:While many disease-associated single nucleotide polymorphisms (SNPs) are associated with gene expression (expression quantitative trait loci, eQTLs), a large proportion of complex disease genome-wide association study (GWAS) variants are of unknown function. Some of these SNPs may contribute to disease by regulating gene splicing. Here, we investigate whether SNPs that are associated with alternative splicing (splice QTL or sQTL) can identify novel functions for existing GWAS variants or suggest new associated variants in chronic obstructive pulmonary disease (COPD). RNA sequencing was performed on whole blood from 376 subjects from the COPDGene Study. Using linear models, we identified 561,060 unique sQTL SNPs associated with 30,333 splice sites corresponding to 6,419 unique genes. Similarly, 708,928 unique eQTL SNPs involving 15,913 genes were detected at 10% FDR. While there is overlap between sQTLs and eQTLs, 55.3% of sQTLs are not eQTLs. Co-localization analysis revealed that 7 out of 21 loci associated with COPD (p<1x10-6) in a published GWAS have at least one shared causal variant between the GWAS and sQTL studies. Among the genes identified to have splice sites associated with top GWAS SNPs was FBXO38, in which a novel exon was discovered to be protective against COPD. Importantly, the sQTL in this locus was validated by qPCR in both blood and lung tissue, demonstrating that splice variants relevant to lung tissue can be identified in blood. Other identified genes included CDK11A and SULT1A2. Overall, these data indicate that analysis of alternative splicing can provide novel insights into disease mechanisms. In particular, we demonstrated that SNPs in a known COPD GWAS locus on chromosome 5q32 influence alternative splicing in the gene FBXO38.While it is known that chronic obstructive pulmonary disease (COPD) is caused in part by genetic factors, few studies have identified specific causative genes. Genetic variants that alter the expression levels of genes have explained part of the genetic component of COPD, however, there are additional genetic variants with unknown function. In some genes the protein coding sequence can be altered by a mechanism known as RNA splicing. We hypothesized that some genetic variants that are associated with risk of COPD contribute to the disease by altering RNA splicing. In this study, we identified genetic variants that are associated both with COPD risk and RNA splicing. In particular, we found that a COPD associated variant of previously unknown function may contribute to the inclusion of a new exon in the FBXO38 gene. These finding are significant because they indicate that analysis of RNA splicing can help identify genes that contribute to disease.

Partial correlation network analysis identifies coordinated gene expression within a regional cluster of COPD genome-wide association signals

Integration of Genomic and Genetic Approaches Implicates IREB2 As a COPD Susceptibility Gene.

Identifying targets for COPD treatment through gene expression analyses.

Integrating Genetics, Transcriptomics, and Proteomics in Lung Tissue to Investigate COPD

Overlap between COPD genetic association results and transcriptional quantitative trait loci

Identification and Characterization of a ceRNA Regulatory Network Involving LINC00482 and PRRC2B in Peripheral Blood Mononuclear Cells: Implications for COPD Pathogenesis and Diagnosis

Hub genes PRPF19 and PPIB in relation to COPD: A Mendelian Randomization investigation

Proteomic networks and related genetic variants associated with smoking and chronic obstructive pulmonary disease

Genetic Regulation of Gene Expression in the Lung Identifiescst3andcd22as Potential Causal Genes for Airflow Obstruction

Identification of the Key Genes in Chronic Obstructive Pulmonary Disease by Weighted Gene Co-Expression Network Analysis.

Leveraging lung tissue transcriptome to uncover candidate causal genes in COPD genetic associations.

Bipartite Community Structure of eQTLs

HHIP protein interactions in lung cells provide insight into COPD pathogenesis

Analysis of genetically driven alternative splicing identifies FBXO38 as a novel COPD susceptibility gene

A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci

Leveraging lung tissue transcriptome to uncover candidate causal genes in COPD genetic associations

Identification of Susceptible Genes for Chronic Obstructive Pulmonary Disease with Lung Adenocarcinoma by Weighted Gene Co-Expression Network Analysis

An integrative network-based approach to identify driving gene communities in chronic obstructive pulmonary disease

Analysis of network expression and immune infiltration of disulfidptosis‐related genes in chronic obstructive pulmonary disease

Understanding the role of the chromosome 15q25.1 in COPD through epigenetics and transcriptomics

RNA-sequencing across three matched tissues reveals shared and tissue-specific gene expression and pathway signatures of COPD